COMMD10 and colorectal cancer: Moreover, COMMD10 exhibits molecular biology mechanisms in colorectal cancer similar to COMMD1, blocking the activation of the NF-κB pathway by reducing p65 nuclear translocation, thereby inhibiting the invasion and metastasis of colorectal cancer 39, 40.